Samphire Neuroscience Launches CycleSync AI Scheduler
UK-based Samphire Neuroscience on Feb. 9 unveiled CycleSync, a patented AI-driven session-scheduling system that personalizes at-home neurostimulation for menstrual symptoms. Integrated with Samphire’s Nettle and Lutea wearables, CycleSync analyzes user-reported fatigue, stress and cycle markers plus treatment responses to adjust timing and dose; the company cites an IEEE trial reporting 67% mood improvement and 72% pain reduction.
Key Points
- 1Launches CycleSync, an AI-driven session-scheduling system integrated with Nettle and Lutea wearables.
- 2Adapts timing and dose by analyzing symptoms, cycle changes, and user feedback for personalized neurostimulation.
- 3Enables clinicians and users to tailor at-home neurostimulation, potentially improving treatment for hormone-linked conditions.
Scoring Rationale
Product launch offers personalized AI neurostimulation with supporting clinical data; promotional coverage and limited independent validation constrain impact.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems
